![Donal O'Dwyer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donal O'Dwyer
Directeur/Membre du Conseil chez
EPIMINDER LIMITED
Fortune : 211 403 $ au 31/05/2026
Profil
Donal Paul O'Dwyer is currently Chairman at Endoluminal Sciences Pty Ltd. since 2005, Chairman at AtCor Medical Pty Ltd. since 2004, Independent Non-Executive Director at Epiminder Ltd. starting 2025, and Trustee at Dundrum Super Fund.
Former roles include Non-Executive Chairman at Conneqt Health Ltd. from 2009 to 2019, Independent Non-Executive Director at Fisher & Paykel Healthcare Corp.
Ltd. from 2012 to 2023, Independent Non-Executive Director at Nuwellis, Inc. from 2011 to 2013, Independent Non-Executive Director at Cochlear Ltd. from 2005 to 2020, Independent Non-Executive Director at Mesoblast Ltd. from 2004 to 2022, Director at Cordis Asset Management Pty Ltd., Director at Grand United Corporate Health Ltd., Independent Non-Executive Director at NIB Holdings Ltd. from 2016 to 2025, Independent Non-Executive Director at nib health funds Ltd., Worldwide President at Cordis Cardiology from 2000 to 2004, President at Cardiovascular Group from 2000 to 2004, Plant Manager at Baxter Healthcare SA (Ireland), and President at Edwards Lifesciences Ltd. (United Kingdom).
Education includes undergraduate studies at University College Dublin and an MBA from Manchester Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NIB HOLDINGS LTD 0,01 % | 06/11/2025 | 43 985 ( 0,01 % ) | 211 403 $ | 31/05/2026 |
Postes actifs de Donal O'Dwyer
| Sociétés | Poste | Début |
|---|---|---|
| EPIMINDER LIMITED | Directeur/Membre du Conseil | 30/04/2025 |
Dundrum Super Fund | Directeur/Membre du Conseil | - |
Atcor Medical Pty Ltd. | Président | 01/11/2004 |
Endoluminal Sciences Pty Ltd.
 Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Develops novel platform technologies for endovascular prostheses | Président | 27/05/2010 |
Anciens postes connus de Donal O'Dwyer
| Sociétés | Poste | Fin |
|---|---|---|
nib health funds Ltd.
 nib health funds Ltd. Multi-Line InsuranceFinance Provides health, life and travel insurance services | Directeur/Membre du Conseil | 06/11/2025 |
| NIB HOLDINGS LIMITED | Directeur/Membre du Conseil | 06/11/2025 |
| FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED | Directeur/Membre du Conseil | 31/12/2023 |
| MESOBLAST LIMITED | Directeur/Membre du Conseil | 25/02/2022 |
| COCHLEAR LIMITED | Directeur/Membre du Conseil | 20/10/2020 |
Formation de Donal O'Dwyer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
19
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 19 |
|---|---|
Fisher & Paykel Healthcare Corp. Ltd.
 Fisher & Paykel Healthcare Corp. Ltd. Medical SpecialtiesHealth Technology Designs, manufactures and markets healthcare devices | Health Technology |
Nuwellis, Inc.
 Nuwellis, Inc. Medical SpecialtiesHealth Technology Develops heart assist devices | Health Technology |
Conneqt Health Ltd.
 Conneqt Health Ltd. Medical SpecialtiesHealth Technology Designs manufacture and markets medical devices for use in cardiovascular management | Health Technology |
NIB Holdings Ltd.
 NIB Holdings Ltd. Multi-Line InsuranceFinance Provides health and medical insurance services | Finance |
Cochlear Ltd.
 Cochlear Ltd. Medical SpecialtiesHealth Technology Develops, manufactures and markets implantable hearing solutions | Health Technology |
University College Dublin
 University College Dublin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mesoblast Ltd.
 Mesoblast Ltd. BiotechnologyHealth Technology Engages in the development and commercialization of biological and adult stem cells products | Health Technology |
nib health funds Ltd.
nib health funds Ltd. Multi-Line InsuranceFinance Provides health, life and travel insurance services | Finance |
Cordis Cardiology
 Cordis Cardiology Miscellaneous Commercial ServicesCommercial Services Engages in development and manufacturing of interventional cardiovascular and endovascular technologies | Commercial Services |
Cardiovascular Group
 Cardiovascular Group Medical/Nursing ServicesHealth Services Provides cardiovascular services | Health Services |
Manchester Business School
 Manchester Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Endoluminal Sciences Pty Ltd.
Endoluminal Sciences Pty Ltd. Medical DistributorsDistribution Services Develops novel platform technologies for endovascular prostheses | Distribution Services |
Baxter Healthcare SA (Ireland)
 Baxter Healthcare SA (Ireland) Medical SpecialtiesHealth Technology Manufactures groundbreaking medical products | Health Technology |
Atcor Medical Pty Ltd. | |
Dundrum Super Fund | |
Grand United Corporate Health Ltd.
 Grand United Corporate Health Ltd. Insurance Brokers/ServicesFinance Specializes in corporate health insurance services | Finance |
Edwards Lifesciences Ltd. (United Kingdom)
 Edwards Lifesciences Ltd. (United Kingdom) Medical DistributorsDistribution Services Distributes medical devices | Distribution Services |
Cordis Asset Management Pty Ltd.
 Cordis Asset Management Pty Ltd. Investment ManagersFinance Provides investment advice | Finance |
Epi-Minder Pty Ltd.
 Epi-Minder Pty Ltd. Electronic Equipment/InstrumentsElectronic Technology Develops EEG monitoring wearable processor | Electronic Technology |
